Indication

Treatment of activated phosphoinositide 3-kinase delta (P13Kδ) syndrome (APDS) in adult and paediatric patients 12 years of age and older.

Medicine details

Medicine name:
leniolisib (Joenja)
SMC ID:
SMC2836
Pharmaceutical company
Pharming Group NV
BNF chapter
Nutrition and blood
Submission type
Ultra-orphan initial assessment
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC